Can a simple test tell doctors how to treat deadly lung failure?
NCT ID NCT07289711
Summary
This study aims to understand if grouping patients with Acute Respiratory Distress Syndrome (ARDS) by their level of inflammation can help doctors choose better treatments. Researchers will follow 500 adults in China with severe ARDS to see if using a model to classify them as 'high' or 'low' inflammation leads to more personalized care decisions, like how much fluid to give or whether to use steroids. The main goal is to gather knowledge to build better future treatment strategies, not to test a new drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhongda Hospital, School of Medicine, Southeast University
RECRUITINGNanjing, Jiangsu, 210009, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.